scispace - formally typeset
T

Takahiro Yano

Researcher at National Institutes of Health

Publications -  21
Citations -  1516

Takahiro Yano is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Lymphoma & Follicular lymphoma. The author has an hindex of 13, co-authored 21 publications receiving 1482 citations. Previous affiliations of Takahiro Yano include University of Alabama at Birmingham.

Papers
More filters
Journal ArticleDOI

p53 mutation is associated with progression in follicular lymphomas

TL;DR: Serial biopsies from 34 patients with follicular lymphomas that underwent histologic transformation, for abnormalities of the p53 tumor suppressor gene by a combination of immunohistochemistry, single strand conformation polymorphism analysis (SSCP), and sequencing suggest that p53 positive low-grade lymphomas are at risk for progression and that in this subset, aggressive therapy may be warranted.
Journal ArticleDOI

MYC rearrangements in histologically progressed follicular lymphomas

TL;DR: The presence of MYC rearrangements in a small fraction of progressed aggressive lymphomas, and not in the corresponding antecedent follicular lymphoma, suggests that acquisition of a MYC reshaping is in some cases associated with the transformation event.
Journal ArticleDOI

Angiocentric immunoproliferative lesions: a molecular analysis of eight cases.

TL;DR: In this paper, the authors used restriction fragment analysis, the Southern blot technique, and probes to assess the configuration of the T-cell receptor β, γ, and δ chain genes and the immunoglobulin heavy and K light chain genes.
Journal ArticleDOI

Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences.

TL;DR: LAZ3 rearrangements occur in a significant fraction of de novo DAL as well as in a smaller subset of indolent and transformed follicular lymphomas and mutation of the LAZ3 gene does not contribute to its putative oncogenic role in most 3q27 translocated B-cell lymphomas.
Journal ArticleDOI

Sequential analysis of 43 patients with non-Hodgkin's lymphoma: clinical correlations with cytogenetic, histologic, immunophenotyping, and molecular studies.

TL;DR: This study correlated cytogenetic, histopathologic, molecular, and clinical parameters of 325 cytogenetically analyzed non-Hodgkin's lymphoma patients studied over the past decade to find patients with low-grade lymphomas were as likely as patients with intermediate- or high- grade lymphomas to acquire new chromosomal abnormalities with time to acquire these abnormalities.